Monarch Medical Technologies develops clinical software that helps hospitals deliver safe, patient-specific insulin therapy. Our mission is to improve inpatient glycemic outcomes by combining evidence-based clinical algorithms, analytics, and workflow tools that reduce hypoglycemia and optimize insulin dosing across care teams. We partner with health systems to implement scalable solutions that fit existing clinical and IT workflows.

EndoTool is a patient-specific insulin management platform that predicts individual responses to insulin and provides precise dosing recommendations for intravenous and subcutaneous therapy. It delivers real-time advisories and analytics to support clinicians and quality teams. EndoTool is an FDA-cleared Class II medical device for inpatient use and is developed and marketed by Monarch Medical Technologies, a Glooko company. Trusted by leading hospitals, EndoTool focuses on safety, simplicity, and measurable clinical outcomes.